Grifols SA (GRFS)
7.98
-0.13
(-1.60%)
USD |
NASDAQ |
May 22, 16:00
7.98
0.00 (0.00%)
Pre-Market: 20:00
Grifols Cash from Investing (Quarterly) : -138.05M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1037M |
| Amarin Corp. Plc | -8.284M |
| Cellectis SA | -6.187M |
| Akari Therapeutics Plc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 128.69M |
| Cash from Financing (Quarterly) | -152.09M |
| Free Cash Flow | 680.05M |
| Free Cash Flow Per Share (Quarterly) | 0.0344 |
| Free Cash Flow to Equity (Quarterly) | -847.83M |
| Free Cash Flow to Firm (Quarterly) | 150.54M |
| Free Cash Flow Yield | 12.53% |